In this prospective randomized clinical trial, 16 (50%) patients underwent SLC (10 left and 6 right) and 16 (50%) patients underwent SILC (8 left and 8 right).
Demographics, preoperative data, and characteristics of the tumor were similar. The mean number of resected lymph nodes was 16 卤 5 in the SLC and 18 卤 6 in the SILC group (P = NS). Surgical time was 124 卤 8 minutes and 147 卤 5 minutes, respectively (P = NS). Surgical mortality was nil and the major morbidity rate was 6.3%in both groups.
SILC for cancer is a technically feasible and safe oncologic procedure with short-term results similar to those obtained with a traditional laparoscopic approach.